Cary D. Austin et al. observed the surface and internal distribution of trastuzumab in cancer cells by EM, which was used to study trastuzumab and ErbB2 in the recycling pathway and the lysosomal pathway (Chalouni and Doll, 2018). Here, ERBB2 is linked to cancer.